Literature DB >> 2401732

Giardiasis: analysis of histological changes in biopsy specimens of 80 patients.

G Oberhuber1, M Stolte.   

Abstract

Histological changes in duodenal biopsy specimens from 80 patients infected with Giardia lamblia were defined and compared with changes in duodenal biopsy specimens from 80 randomly chosen "healthy" patients. Villous architecture, the number of intraepithelial lymphocytes, the occurrence of lymphoid follicles and the density of colonisation by G lamblia trophozoites were examined. Grade 1 villous flattening was observed in 41% of cases positive for Giardia and in 37.5% of the control cases. The mean content of intraepithelial lymphocytes was 24.5 compared with 22.6 intraepithelial lymphocytes/100 epithelial cells in the positive and negative groups, respectively. Lymphoid follicles were more frequently observed in Giardia positive specimens, but their incidence was not significantly higher compared with that of controls. Twenty five per cent of patients positive for Giardia showed light, 41% intermediate, and 34% heavy colonisation by Giardia trophozoites. In 76% the parasites were observed in all specimens obtained. It is concluded that histological changes induced by G lamblia are not specific, and that two duodenal biopsy specimens might suffice to detect the trophozoites.

Entities:  

Mesh:

Year:  1990        PMID: 2401732      PMCID: PMC502644          DOI: 10.1136/jcp.43.8.641

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Nodular lymphoid hyperplasia of the bowel in primary hypogammaglobulinaemia: study of in vivo and in vitro lymphocyte function.

Authors:  A D Webster; S Kenwright; J Ballard; M Shiner; G Slavin; A J Levi; G Loewi; G L Asherson
Journal:  Gut       Date:  1977-05       Impact factor: 23.059

2.  The intestinal immune response in giardiasis.

Authors:  S C Kraft
Journal:  Gastroenterology       Date:  1979-04       Impact factor: 22.682

3.  Relation of giardiasis to abnormal intestinal structure and function in gastrointestinal immunodeficiency syndromes.

Authors:  M E Ament; C E Rubin
Journal:  Gastroenterology       Date:  1972-02       Impact factor: 22.682

4.  Immunocytochemical characterization of the lymphocytes in nodular lymphoid hyperplasia of the bowel.

Authors:  H Nagura; P F Kohler; W R Brown
Journal:  Lab Invest       Date:  1979-01       Impact factor: 5.662

5.  Occurrence of Giardia lamblia in children in day care centers.

Authors:  L K Pickering; W E Woodward; H L DuPont; P Sullivan
Journal:  J Pediatr       Date:  1984-04       Impact factor: 4.406

6.  Quantification of the lymphocytic infiltrate in jejunal epithelium in giardiasis.

Authors:  S G Wright; A M Tomkins
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

7.  Direct and antibody dependent cell mediated cytotoxicity against Giardia lamblia by splenic and intestinal lymphoid cells in mice.

Authors:  S S Kanwar; N K Ganguly; B N Walia; R C Mahajan
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

8.  Quantitative histological and immunohistochemical findings in jejunal biopsy specimens in giardiasis.

Authors:  P C Rosekrans; J Lindeman; C J Meijer
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

9.  Genetic studies in human and murine giardiasis.

Authors:  I C Roberts-Thomson; G F Mitchell; R F Anders; B D Tait; P Kerlin; A Kerr-Grant; P Cavanagh
Journal:  Gut       Date:  1980-05       Impact factor: 23.059

10.  Diagnosis of giardiasis by specific IgM antibody enzyme-linked immunosorbent assay.

Authors:  A K Goka; D D Rolston; V I Mathan; M J Farthing
Journal:  Lancet       Date:  1986-07-26       Impact factor: 79.321

  10 in total
  10 in total

Review 1.  An approach to duodenal biopsies.

Authors:  S Serra; P A Jani
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

2.  The course of experimental giardiasis in Mongolian gerbil.

Authors:  Radka Pecková; Bohumil Sak; Dana Květoňová; Martin Kváč; Eva Koriťáková; Ivona Foitová
Journal:  Parasitol Res       Date:  2018-05-24       Impact factor: 2.289

3.  Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis.

Authors:  G Oberhuber; H Vogelsang; M Stolte; S Muthenthaler; J A Kummer; A J Kummer; T Radaszkiewicz
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

4.  Giardiasis of the stomach.

Authors:  D M Berney; D Rampton; J D van der Walt
Journal:  Postgrad Med J       Date:  1994-03       Impact factor: 2.401

5.  Diagnostic yield of duodenal aspirate for G. lamblia and comparison to duodenal mucosal biopsies.

Authors:  Sandeep K Gupta; Joseph M Croffie; Marian D Pfefferkorn; Joseph F Fitzgerald
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

6.  Gastric giardiasis.

Authors:  C Doglioni; M De Boni; R Cielo; L Laurino; P Pelosio; P Braidotti; G Viale
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

7.  Chronic giardiasis of the stomach.

Authors:  C Quincey; P D James; R J Steele
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

8.  Modeling long-term host cell-Giardia lamblia interactions in an in vitro co-culture system.

Authors:  Bridget S Fisher; Carlos E Estraño; Judith A Cole
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

9.  Giardia lamblia miRNAs as a new diagnostic tool for human giardiasis.

Authors:  Tal Meningher; Daniel Boleslavsky; Iris Barshack; Hila Tabibian-Keissar; Refael Kohen; Devorah Gur-Wahnon; Iddo Z Ben-Dov; Yechezkel Sidi; Dror Avni; Eli Schwartz
Journal:  PLoS Negl Trop Dis       Date:  2019-06-17

10.  Prolonged Duodenal Mucosal Lymphocyte Alterations in Patients With and Without Postinfectious Functional Gastrointestinal Disorders After Giardia Infection.

Authors:  Vernesa Dizdar; Trygve Hausken; Ole D Laerum; Odd Helge Gilja; Nina Langeland; Kurt Hanevik
Journal:  J Infect Dis       Date:  2019-06-19       Impact factor: 5.226

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.